Small cell lung cancer presenting with SVC stenosis and pulmonary emboli: stenting and anticoagulation before oncology follow-up

This lung cancer diagnosis at a glance

Subtype
Small Cell Lung Cancer
Biomarkers
Synaptophysin-positive; chromogranin-positive; CD56-positive; TTF1-positive; BCL-2-positive
Sex
Female
Treatment
supportive care and interventional procedure
Outcome
Care Ongoing

Treatment course, step by step

  1. CT pulmonary angiography showed right suprahilar mass about 5.2 × 5.1 cm with severe right upper-lobe pulmonary artery compression, severe short-segment SVC narrowing, and left upper/lower lobe segmental/subsegmental pulmonary emboli
  2. heparin drip started
  3. venogram confirmed severe SVC stenosis from infiltrating mass
  4. intravascular biopsy using HawkOne system confirmed SCLC by immunostaining
  5. 12 mm × 6 cm Abre stent placed across SVC stenosis followed by in-stent venoplasty with 12 mm and 14 mm balloons
  6. transitioned to direct oral anticoagulant
  7. discharged with near-full symptom resolution and outpatient oncology follow-up planned.

What happened, in summary

This 59-year-old woman came to the emergency department with worsening headaches, shortness of breath, and swelling of the face and both arms over 2 weeks. Her medical history included diabetes mellitus, coronary artery bypass grafting, and cocaine abuse. Examination showed diffuse facial swelling and bilateral upper-extremity swelling, while routine laboratory tests were largely unremarkable. CT pulmonary angiography revealed a right suprahilar mass measuring about 5.2 × 5.1 cm. The mass severely compressed a right upper-lobe pulmonary artery branch and caused severe short-segment narrowing of the superior vena cava, or SVC. The scan also showed left upper- and lower-lobe segmental and subsegmental pulmonary emboli without right-heart strain. A heparin drip was started, and interventional radiology was consulted. Venography confirmed severe SVC stenosis caused by the infiltrating right suprahilar mass. During the procedure, an intravascular biopsy of the mass was obtained using the HawkOne system. A 12 mm × 6 cm Abre stent was then placed across the SVC stenosis below the brachiocephalic vein confluence, with its distal portion near the cavoatrial junction. In-stent venoplasty followed using 12 mm and 14 mm balloons. Immunostaining from the mass was positive for synaptophysin, chromogranin, CD56, TTF1, and BCL-2, consistent with small cell lung cancer. She was transitioned to a direct oral anticoagulant and discharged with near-full symptom resolution. As of June 2024, outpatient oncology follow-up was planned for newly diagnosed SCLC. No systemic chemotherapy or radiation had been started during the reported hospitalization, so cancer-directed treatment was deferred to outpatient care after discharge by oncology.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more lung cancer stories